A leading academic has called for more incentives to boost research and investment in Hong Kong's Chinese medicine.
Dr Paul But Pui-hay of the Chinese University of Hong Kong said the development of traditional herbal medicine has been hit by the lack of infrastructure, and that not enough attention had been paid to product safety.
'There has been no monitoring of the use of Chinese medicine, and no incentive for local investment in quality control.
The market is flooded with products of various quality - and the good ones don't get recognised,' Dr But said.
'Products of better quality can be produced with professional expertise and an efficient infrastructure supplied by the Government.
'Concrete information must back up any policy to control Chinese medicine,' he said.
